Preventing the Development of Asthma

Jeffrey R. Stokes; Leonard Bacharier

doi:10.1016/B978-0-323-48552-4.00016-0

Preventing the Development of Asthma

Jeffrey R. Stokes, Leonard Bacharier

Division of Allergy & Pulmonary Medicine

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

Over 6million children in the United States have asthma. Wheezing illnesses, common in all school age children, are an early sign of asthma in those predisposed. Targeting environmental factors associated with asthma development prenatally or early in life has the best chance of interrupting this progression. High-dose vitamin D and long-chain polyunsaturated fatty acids supplementation during pregnancy have shown promise. Lessening the effect of early life viral respiratory illnesses or altering the microbiome are other targets for intervention. More precise identification of risk factors, endotypes, and phenotypes of asthma will enable more specific and targeted therapies.

Original language	English
Title of host publication	Personalizing Asthma Management for the Clinician
Publisher	Elsevier
Pages	171-178
Number of pages	8
ISBN (Electronic)	9780323485524
ISBN (Print)	9780323497084
DOIs	https://doi.org/10.1016/B978-0-323-48552-4.00016-0
State	Published - Jan 1 2017

Keywords

Asthma prevention
Fish oil
Microbiome
Vitamin D

Access to Document

10.1016/B978-0-323-48552-4.00016-0

Cite this

@inbook{5f67a0945a554a19b0a54129493ca809,

title = "Preventing the Development of Asthma",

abstract = "Over 6million children in the United States have asthma. Wheezing illnesses, common in all school age children, are an early sign of asthma in those predisposed. Targeting environmental factors associated with asthma development prenatally or early in life has the best chance of interrupting this progression. High-dose vitamin D and long-chain polyunsaturated fatty acids supplementation during pregnancy have shown promise. Lessening the effect of early life viral respiratory illnesses or altering the microbiome are other targets for intervention. More precise identification of risk factors, endotypes, and phenotypes of asthma will enable more specific and targeted therapies.",

keywords = "Asthma prevention, Fish oil, Microbiome, Vitamin D",

author = "Stokes, {Jeffrey R.} and Leonard Bacharier",

year = "2017",

month = jan,

day = "1",

doi = "10.1016/B978-0-323-48552-4.00016-0",

language = "English",

isbn = "9780323497084",

pages = "171--178",

booktitle = "Personalizing Asthma Management for the Clinician",

publisher = "Elsevier",

}

TY - CHAP

T1 - Preventing the Development of Asthma

AU - Stokes, Jeffrey R.

AU - Bacharier, Leonard

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Over 6million children in the United States have asthma. Wheezing illnesses, common in all school age children, are an early sign of asthma in those predisposed. Targeting environmental factors associated with asthma development prenatally or early in life has the best chance of interrupting this progression. High-dose vitamin D and long-chain polyunsaturated fatty acids supplementation during pregnancy have shown promise. Lessening the effect of early life viral respiratory illnesses or altering the microbiome are other targets for intervention. More precise identification of risk factors, endotypes, and phenotypes of asthma will enable more specific and targeted therapies.

AB - Over 6million children in the United States have asthma. Wheezing illnesses, common in all school age children, are an early sign of asthma in those predisposed. Targeting environmental factors associated with asthma development prenatally or early in life has the best chance of interrupting this progression. High-dose vitamin D and long-chain polyunsaturated fatty acids supplementation during pregnancy have shown promise. Lessening the effect of early life viral respiratory illnesses or altering the microbiome are other targets for intervention. More precise identification of risk factors, endotypes, and phenotypes of asthma will enable more specific and targeted therapies.

KW - Asthma prevention

KW - Fish oil

KW - Microbiome

KW - Vitamin D

UR - http://www.scopus.com/inward/record.url?scp=85140700967&partnerID=8YFLogxK

U2 - 10.1016/B978-0-323-48552-4.00016-0

DO - 10.1016/B978-0-323-48552-4.00016-0

M3 - Chapter

AN - SCOPUS:85054288449

SN - 9780323497084

SP - 171

EP - 178

BT - Personalizing Asthma Management for the Clinician

PB - Elsevier

ER -

Preventing the Development of Asthma

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this